Clinical Study
Cardiovascular Autonomic Neuropathy in Context of Other Complications of Type 2 Diabetes Mellitus
Table 3
Univariate logistic regression analysis (CAN+, CAN− patient groups).
| Variable | Odds ratio | 95% CI | P value |
| Male/Female | 0.90 | 0.4682 to 1.7569 | 0.772 | Age (years) | 1.02 | 0.9864 to 1.0688 | 0.19 | Age diabetes dg. (years) | 0.89 | 0.8571 to 0.9402 | <0,0001 | Diabetes duration (years) | 1.6797 | 1.4278 to 1.9760 | 0.0001 | Body mass index (kg/m2) | 1.13 | 1.0588 to 1.2139 | 0.0003 | SBP (mmHg) | 1.01 | 1.0000 to 1.0360 | 0.05 | DBP (mmHg) | 1.0046 | 0.9710 to 1.0394 | 0.78 | HT (yes) | 1.56 | 0.7656 to 3.2024 | 0.21 | SCORE | 1.12 | 1.0425 to 1.2069 | 0.002 | Smoking (yes versus no) | 2.22 | 1.1327 to 4.3598 | 0.02 | Severity of smoking (>20 versus <20 cigarettes/day) | 1.29 | 0.4773 to 3.5148 | 0.6115 | Cholesterol (mg%) | 1.01 | 1.0041 to 1.0189 | 0.0023 | Triglycerides (mg%) | 1.0024 | 0.9999 to 1.0049 | 0.0633 | HbA1c | 1.83 | 1.3826 to 2.4302 | <0.0001 | Treatment of diabetes | 3.0000 | 1.3458 to 6.6873 | 0.0072 | FPG (mg%) | 1.0061 | 1.0008 to 1.0115 | 0.02 | eGFR (mL/min per 1.73 m2) | 0.90 | 0.8808 to 0.9376 | <0.0001 | ABI | 0.0046 | 0.0002 to 0.0944 | 0.0005 | QTC | 1.05 | 1.0341 to 1.0728 | <0.0001 | IMT | 12.48 | 8.21 to 18.32 | <0.0001 | Retinopathy (yes versus no) | 16.5306 | 2.0342 to 134.3347 | 0.008 | Peripheral neuropathy (yes versus no) | 29.9444 | 12.0439 to 74.4503 | 0.0001 |
|
|
SBP: systolic blood pressure, DBP: diastolic blood pressure, HT: hypertension, SCORE: systematic coronary risk evaluation, HbA1c: glycosylated hemoglobin, FPG: fasting plasma glucose, eGFR: estimated glomerular filtration rate, ABI: ankle-brachial index, IMT: intima-media thickness, and QTC: corrected QT interval.
|